Cite
MLA Citation
R.G.B. Langley et al.. “THU0187 Safety of Tofacitinib, An Oral Janus Kinase Inhibitor: Integrated Data Analysis from The Global Chronic Plaque Psoriasis Clinical Trials.” Annals of the rheumatic diseases, vol. 75, n.d., p. 253. http://access.bl.uk/ark:/81055/vdc_100135142519.0x000053